- Home
- VRDN vs ALEX Comparison
VRDN vs ALEX Comparison
Compare VRDN & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- ALEX
- Stock Information
- Founded
- VRDN 2006
- ALEX 1870
- Country
- VRDN United States
- ALEX United States
- Employees
- VRDN N/A
- ALEX N/A
- Industry
- VRDN Medical Specialities
- ALEX Real Estate Investment Trusts
- Sector
- VRDN Health Care
- ALEX Real Estate
- Exchange
- VRDN Nasdaq
- ALEX Nasdaq
- Market Cap
- VRDN 1.6B
- ALEX 1.3B
- IPO Year
- VRDN N/A
- ALEX N/A
- Fundamental
- Price
- VRDN $16.27
- ALEX $17.61
- Analyst Decision
- VRDN Buy
- ALEX Buy
- Analyst Count
- VRDN 12
- ALEX 3
- Target Price
- VRDN $36.44
- ALEX $22.50
- AVG Volume (30 Days)
- VRDN 979.5K
- ALEX 254.9K
- Earning Date
- VRDN 03-04-2025
- ALEX 02-27-2025
- Dividend Yield
- VRDN N/A
- ALEX 5.11%
- EPS Growth
- VRDN N/A
- ALEX N/A
- EPS
- VRDN N/A
- ALEX 0.61
- Revenue
- VRDN $302,000.00
- ALEX $230,949,000.00
- Revenue This Year
- VRDN $3.30
- ALEX N/A
- Revenue Next Year
- VRDN N/A
- ALEX N/A
- P/E Ratio
- VRDN N/A
- ALEX $21.48
- Revenue Growth
- VRDN N/A
- ALEX 1.30
- 52 Week Low
- VRDN $11.40
- ALEX $15.53
- 52 Week High
- VRDN $27.20
- ALEX $20.30
- Technical
- Relative Strength Index (RSI)
- VRDN 36.43
- ALEX 43.41
- Support Level
- VRDN $15.62
- ALEX $17.48
- Resistance Level
- VRDN $18.15
- ALEX $18.09
- Average True Range (ATR)
- VRDN 0.91
- ALEX 0.24
- MACD
- VRDN -0.20
- ALEX -0.02
- Stochastic Oscillator
- VRDN 14.48
- ALEX 21.31
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc operates in the real estate sector. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces and also urban ground leases in Hawaii, thereby accounting for majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.